1 Market Overview 1.1 Pediatric Influenza Treatment Product Introduction 1.2 Global Pediatric Influenza Treatment Market Size Forecast 1.3 Pediatric Influenza Treatment Market Trends & Drivers 1.3.1 Pediatric Influenza Treatment Industry Trends 1.3.2 Pediatric Influenza Treatment Market Drivers & Opportunity 1.3.3 Pediatric Influenza Treatment Market Challenges 1.3.4 Pediatric Influenza Treatment Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Pediatric Influenza Treatment Players Revenue Ranking (2023) 2.2 Global Pediatric Influenza Treatment Revenue by Company (2019-2024) 2.3 Key Companies Pediatric Influenza Treatment Manufacturing Base Distribution and Headquarters 2.4 Key Companies Pediatric Influenza Treatment Product Offered 2.5 Key Companies Time to Begin Mass Production of Pediatric Influenza Treatment 2.6 Pediatric Influenza Treatment Market Competitive Analysis 2.6.1 Pediatric Influenza Treatment Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Pediatric Influenza Treatment Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Influenza Treatment as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Antiviral Drug 3.1.2 Antipyretic 3.1.3 Neuraminidase inhibitor 3.1.4 Others 3.2 Global Pediatric Influenza Treatment Sales Value by Type 3.2.1 Global Pediatric Influenza Treatment Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Pediatric Influenza Treatment Sales Value, by Type (2019-2030) 3.2.3 Global Pediatric Influenza Treatment Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Hospitals 4.1.2 Clinics 4.1.3 Ambulatory Surgical Centers 4.1.4 Others 4.2 Global Pediatric Influenza Treatment Sales Value by Application 4.2.1 Global Pediatric Influenza Treatment Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Pediatric Influenza Treatment Sales Value, by Application (2019-2030) 4.2.3 Global Pediatric Influenza Treatment Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Pediatric Influenza Treatment Sales Value by Region 5.1.1 Global Pediatric Influenza Treatment Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Pediatric Influenza Treatment Sales Value by Region (2019-2024) 5.1.3 Global Pediatric Influenza Treatment Sales Value by Region (2025-2030) 5.1.4 Global Pediatric Influenza Treatment Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Pediatric Influenza Treatment Sales Value, 2019-2030 5.2.2 North America Pediatric Influenza Treatment Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Pediatric Influenza Treatment Sales Value, 2019-2030 5.3.2 Europe Pediatric Influenza Treatment Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Pediatric Influenza Treatment Sales Value, 2019-2030 5.4.2 Asia Pacific Pediatric Influenza Treatment Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Pediatric Influenza Treatment Sales Value, 2019-2030 5.5.2 South America Pediatric Influenza Treatment Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Pediatric Influenza Treatment Sales Value, 2019-2030 5.6.2 Middle East & Africa Pediatric Influenza Treatment Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Pediatric Influenza Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Pediatric Influenza Treatment Sales Value 6.3 United States 6.3.1 United States Pediatric Influenza Treatment Sales Value, 2019-2030 6.3.2 United States Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Pediatric Influenza Treatment Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Pediatric Influenza Treatment Sales Value, 2019-2030 6.4.2 Europe Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Pediatric Influenza Treatment Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Pediatric Influenza Treatment Sales Value, 2019-2030 6.5.2 China Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 6.5.3 China Pediatric Influenza Treatment Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Pediatric Influenza Treatment Sales Value, 2019-2030 6.6.2 Japan Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Pediatric Influenza Treatment Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Pediatric Influenza Treatment Sales Value, 2019-2030 6.7.2 South Korea Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Pediatric Influenza Treatment Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Pediatric Influenza Treatment Sales Value, 2019-2030 6.8.2 Southeast Asia Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Pediatric Influenza Treatment Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Pediatric Influenza Treatment Sales Value, 2019-2030 6.9.2 India Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 6.9.3 India Pediatric Influenza Treatment Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 F. Hoffmann-La Roche Ltd 7.1.1 F. Hoffmann-La Roche Ltd Profile 7.1.2 F. Hoffmann-La Roche Ltd Main Business 7.1.3 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Products, Services and Solutions 7.1.4 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Revenue (US$ Million) & (2019-2024) 7.1.5 F. Hoffmann-La Roche Ltd Recent Developments 7.2 GlaxoSmithKline Plc. 7.2.1 GlaxoSmithKline Plc. Profile 7.2.2 GlaxoSmithKline Plc. Main Business 7.2.3 GlaxoSmithKline Plc. Pediatric Influenza Treatment Products, Services and Solutions 7.2.4 GlaxoSmithKline Plc. Pediatric Influenza Treatment Revenue (US$ Million) & (2019-2024) 7.2.5 GlaxoSmithKline Plc. Recent Developments 7.3 NATCO Pharma Limited. 7.3.1 NATCO Pharma Limited. Profile 7.3.2 NATCO Pharma Limited. Main Business 7.3.3 NATCO Pharma Limited. Pediatric Influenza Treatment Products, Services and Solutions 7.3.4 NATCO Pharma Limited. Pediatric Influenza Treatment Revenue (US$ Million) & (2019-2024) 7.3.5 NESHER PHARMS Recent Developments 7.4 NESHER PHARMS 7.4.1 NESHER PHARMS Profile 7.4.2 NESHER PHARMS Main Business 7.4.3 NESHER PHARMS Pediatric Influenza Treatment Products, Services and Solutions 7.4.4 NESHER PHARMS Pediatric Influenza Treatment Revenue (US$ Million) & (2019-2024) 7.4.5 NESHER PHARMS Recent Developments 7.5 Johnson & Johnsons Inc. 7.5.1 Johnson & Johnsons Inc. Profile 7.5.2 Johnson & Johnsons Inc. Main Business 7.5.3 Johnson & Johnsons Inc. Pediatric Influenza Treatment Products, Services and Solutions 7.5.4 Johnson & Johnsons Inc. Pediatric Influenza Treatment Revenue (US$ Million) & (2019-2024) 7.5.5 Johnson & Johnsons Inc. Recent Developments 7.6 Cipla 7.6.1 Cipla Profile 7.6.2 Cipla Main Business 7.6.3 Cipla Pediatric Influenza Treatment Products, Services and Solutions 7.6.4 Cipla Pediatric Influenza Treatment Revenue (US$ Million) & (2019-2024) 7.6.5 Cipla Recent Developments 7.7 Hetero Pharma 7.7.1 Hetero Pharma Profile 7.7.2 Hetero Pharma Main Business 7.7.3 Hetero Pharma Pediatric Influenza Treatment Products, Services and Solutions 7.7.4 Hetero Pharma Pediatric Influenza Treatment Revenue (US$ Million) & (2019-2024) 7.7.5 Hetero Pharma Recent Developments 7.8 Teva Pharmaceutical pvt. Ltd. 7.8.1 Teva Pharmaceutical pvt. Ltd. Profile 7.8.2 Teva Pharmaceutical pvt. Ltd. Main Business 7.8.3 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Products, Services and Solutions 7.8.4 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Revenue (US$ Million) & (2019-2024) 7.8.5 Teva Pharmaceutical pvt. Ltd. Recent Developments 7.9 Olainfarm JSC 7.9.1 Olainfarm JSC Profile 7.9.2 Olainfarm JSC Main Business 7.9.3 Olainfarm JSC Pediatric Influenza Treatment Products, Services and Solutions 7.9.4 Olainfarm JSC Pediatric Influenza Treatment Revenue (US$ Million) & (2019-2024) 7.9.5 Olainfarm JSC Recent Developments 7.10 Gilead Sciences, Inc. 7.10.1 Gilead Sciences, Inc. Profile 7.10.2 Gilead Sciences, Inc. Main Business 7.10.3 Gilead Sciences, Inc. Pediatric Influenza Treatment Products, Services and Solutions 7.10.4 Gilead Sciences, Inc. Pediatric Influenza Treatment Revenue (US$ Million) & (2019-2024) 7.10.5 Gilead Sciences, Inc. Recent Developments 8 Industry Chain Analysis 8.1 Pediatric Influenza Treatment Industrial Chain 8.2 Pediatric Influenza Treatment Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Pediatric Influenza Treatment Sales Model 8.5.2 Sales Channel 8.5.3 Pediatric Influenza Treatment Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Pediatric Influenza Treatment Market Trends Table 2. Pediatric Influenza Treatment Market Drivers & Opportunity Table 3. Pediatric Influenza Treatment Market Challenges Table 4. Pediatric Influenza Treatment Market Restraints Table 5. Global Pediatric Influenza Treatment Revenue by Company (2019-2024) & (US$ Million) Table 6. Global Pediatric Influenza Treatment Revenue Market Share by Company (2019-2024) Table 7. Key Companies Pediatric Influenza Treatment Manufacturing Base Distribution and Headquarters Table 8. Key Companies Pediatric Influenza Treatment Product Type Table 9. Key Companies Time to Begin Mass Production of Pediatric Influenza Treatment Table 10. Global Pediatric Influenza Treatment Companies Market Concentration Ratio (CR5 and HHI) Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Influenza Treatment as of 2023) Table 12. Mergers & Acquisitions, Expansion Plans Table 13. Global Pediatric Influenza Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million) Table 14. Global Pediatric Influenza Treatment Sales Value by Type (2019-2024) & (US$ Million) Table 15. Global Pediatric Influenza Treatment Sales Value by Type (2025-2030) & (US$ Million) Table 16. Global Pediatric Influenza Treatment Sales Market Share in Value by Type (2019-2024) & (%) Table 17. Global Pediatric Influenza Treatment Sales Market Share in Value by Type (2025-2030) & (%) Table 18. Global Pediatric Influenza Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million) Table 19. Global Pediatric Influenza Treatment Sales Value by Application (2019-2024) & (US$ Million) Table 20. Global Pediatric Influenza Treatment Sales Value by Application (2025-2030) & (US$ Million) Table 21. Global Pediatric Influenza Treatment Sales Market Share in Value by Application (2019-2024) & (%) Table 22. Global Pediatric Influenza Treatment Sales Market Share in Value by Application (2025-2030) & (%) Table 23. Global Pediatric Influenza Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 24. Global Pediatric Influenza Treatment Sales Value by Region (2019-2024) & (US$ Million) Table 25. Global Pediatric Influenza Treatment Sales Value by Region (2025-2030) & (US$ Million) Table 26. Global Pediatric Influenza Treatment Sales Value by Region (2019-2024) & (%) Table 27. Global Pediatric Influenza Treatment Sales Value by Region (2025-2030) & (%) Table 28. Key Countries/Regions Pediatric Influenza Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030 Table 29. Key Countries/Regions Pediatric Influenza Treatment Sales Value, (2019-2024) & (US$ Million) Table 30. Key Countries/Regions Pediatric Influenza Treatment Sales Value, (2025-2030) & (US$ Million) Table 31. F. Hoffmann-La Roche Ltd Basic Information List Table 32. F. Hoffmann-La Roche Ltd Description and Business Overview Table 33. F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Products, Services and Solutions Table 34. Revenue (US$ Million) in Pediatric Influenza Treatment Business of F. Hoffmann-La Roche Ltd (2019-2024) Table 35. F. Hoffmann-La Roche Ltd Recent Developments Table 36. GlaxoSmithKline Plc. Basic Information List Table 37. GlaxoSmithKline Plc. Description and Business Overview Table 38. GlaxoSmithKline Plc. Pediatric Influenza Treatment Products, Services and Solutions Table 39. Revenue (US$ Million) in Pediatric Influenza Treatment Business of GlaxoSmithKline Plc. (2019-2024) Table 40. GlaxoSmithKline Plc. Recent Developments Table 41. NATCO Pharma Limited. Basic Information List Table 42. NATCO Pharma Limited. Description and Business Overview Table 43. NATCO Pharma Limited. Pediatric Influenza Treatment Products, Services and Solutions Table 44. Revenue (US$ Million) in Pediatric Influenza Treatment Business of NATCO Pharma Limited. (2019-2024) Table 45. NATCO Pharma Limited. Recent Developments Table 46. NESHER PHARMS Basic Information List Table 47. NESHER PHARMS Description and Business Overview Table 48. NESHER PHARMS Pediatric Influenza Treatment Products, Services and Solutions Table 49. Revenue (US$ Million) in Pediatric Influenza Treatment Business of NESHER PHARMS (2019-2024) Table 50. NESHER PHARMS Recent Developments Table 51. Johnson & Johnsons Inc. Basic Information List Table 52. Johnson & Johnsons Inc. Description and Business Overview Table 53. Johnson & Johnsons Inc. Pediatric Influenza Treatment Products, Services and Solutions Table 54. Revenue (US$ Million) in Pediatric Influenza Treatment Business of Johnson & Johnsons Inc. (2019-2024) Table 55. Johnson & Johnsons Inc. Recent Developments Table 56. Cipla Basic Information List Table 57. Cipla Description and Business Overview Table 58. Cipla Pediatric Influenza Treatment Products, Services and Solutions Table 59. Revenue (US$ Million) in Pediatric Influenza Treatment Business of Cipla (2019-2024) Table 60. Cipla Recent Developments Table 61. Hetero Pharma Basic Information List Table 62. Hetero Pharma Description and Business Overview Table 63. Hetero Pharma Pediatric Influenza Treatment Products, Services and Solutions Table 64. Revenue (US$ Million) in Pediatric Influenza Treatment Business of Hetero Pharma (2019-2024) Table 65. Hetero Pharma Recent Developments Table 66. Teva Pharmaceutical pvt. Ltd. Basic Information List Table 67. Teva Pharmaceutical pvt. Ltd. Description and Business Overview Table 68. Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Products, Services and Solutions Table 69. Revenue (US$ Million) in Pediatric Influenza Treatment Business of Teva Pharmaceutical pvt. Ltd. (2019-2024) Table 70. Teva Pharmaceutical pvt. Ltd. Recent Developments Table 71. Olainfarm JSC Basic Information List Table 72. Olainfarm JSC Description and Business Overview Table 73. Olainfarm JSC Pediatric Influenza Treatment Products, Services and Solutions Table 74. Revenue (US$ Million) in Pediatric Influenza Treatment Business of Olainfarm JSC (2019-2024) Table 75. Olainfarm JSC Recent Developments Table 76. Gilead Sciences, Inc. Basic Information List Table 77. Gilead Sciences, Inc. Description and Business Overview Table 78. Gilead Sciences, Inc. Pediatric Influenza Treatment Products, Services and Solutions Table 79. Revenue (US$ Million) in Pediatric Influenza Treatment Business of Gilead Sciences, Inc. (2019-2024) Table 80. Gilead Sciences, Inc. Recent Developments Table 81. Key Raw Materials Lists Table 82. Raw Materials Key Suppliers Lists Table 83. Pediatric Influenza Treatment Downstream Customers Table 84. Pediatric Influenza Treatment Distributors List Table 85. Research Programs/Design for This Report Table 86. Key Data Information from Secondary Sources Table 87. Key Data Information from Primary Sources Table 88. Business Unit and Senior & Team Lead Analysts List of Figures Figure 1. Pediatric Influenza Treatment Product Picture Figure 2. Global Pediatric Influenza Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Pediatric Influenza Treatment Sales Value (2019-2030) & (US$ Million) Figure 4. Pediatric Influenza Treatment Report Years Considered Figure 5. Global Pediatric Influenza Treatment Players Revenue Ranking (2023) & (US$ Million) Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Pediatric Influenza Treatment Revenue in 2023 Figure 7. Pediatric Influenza Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 8. Antiviral Drug Picture Figure 9. Antipyretic Picture Figure 10. Neuraminidase inhibitor Picture Figure 11. Others Picture Figure 12. Global Pediatric Influenza Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million) Figure 13. Global Pediatric Influenza Treatment Sales Value Market Share by Type, 2023 & 2030 Figure 14. Product Picture of Hospitals Figure 15. Product Picture of Clinics Figure 16. Product Picture of Ambulatory Surgical Centers Figure 17. Product Picture of Others Figure 18. Global Pediatric Influenza Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million) Figure 19. Global Pediatric Influenza Treatment Sales Value Market Share by Application, 2023 & 2030 Figure 20. North America Pediatric Influenza Treatment Sales Value (2019-2030) & (US$ Million) Figure 21. North America Pediatric Influenza Treatment Sales Value by Country (%), 2023 VS 2030 Figure 22. Europe Pediatric Influenza Treatment Sales Value (2019-2030) & (US$ Million) Figure 23. Europe Pediatric Influenza Treatment Sales Value by Country (%), 2023 VS 2030 Figure 24. Asia Pacific Pediatric Influenza Treatment Sales Value (2019-2030) & (US$ Million) Figure 25. Asia Pacific Pediatric Influenza Treatment Sales Value by Country (%), 2023 VS 2030 Figure 26. South America Pediatric Influenza Treatment Sales Value (2019-2030) & (US$ Million) Figure 27. South America Pediatric Influenza Treatment Sales Value by Country (%), 2023 VS 2030 Figure 28. Middle East & Africa Pediatric Influenza Treatment Sales Value (2019-2030) & (US$ Million) Figure 29. Middle East & Africa Pediatric Influenza Treatment Sales Value by Country (%), 2023 VS 2030 Figure 30. Key Countries/Regions Pediatric Influenza Treatment Sales Value (%), (2019-2030) Figure 31. United States Pediatric Influenza Treatment Sales Value, (2019-2030) & (US$ Million) Figure 32. United States Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 Figure 33. United States Pediatric Influenza Treatment Sales Value by Application (%), 2023 VS 2030 Figure 34. Europe Pediatric Influenza Treatment Sales Value, (2019-2030) & (US$ Million) Figure 35. Europe Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 Figure 36. Europe Pediatric Influenza Treatment Sales Value by Application (%), 2023 VS 2030 Figure 37. China Pediatric Influenza Treatment Sales Value, (2019-2030) & (US$ Million) Figure 38. China Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 Figure 39. China Pediatric Influenza Treatment Sales Value by Application (%), 2023 VS 2030 Figure 40. Japan Pediatric Influenza Treatment Sales Value, (2019-2030) & (US$ Million) Figure 41. Japan Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 Figure 42. Japan Pediatric Influenza Treatment Sales Value by Application (%), 2023 VS 2030 Figure 43. South Korea Pediatric Influenza Treatment Sales Value, (2019-2030) & (US$ Million) Figure 44. South Korea Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 Figure 45. South Korea Pediatric Influenza Treatment Sales Value by Application (%), 2023 VS 2030 Figure 46. Southeast Asia Pediatric Influenza Treatment Sales Value, (2019-2030) & (US$ Million) Figure 47. Southeast Asia Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 Figure 48. Southeast Asia Pediatric Influenza Treatment Sales Value by Application (%), 2023 VS 2030 Figure 49. India Pediatric Influenza Treatment Sales Value, (2019-2030) & (US$ Million) Figure 50. India Pediatric Influenza Treatment Sales Value by Type (%), 2023 VS 2030 Figure 51. India Pediatric Influenza Treatment Sales Value by Application (%), 2023 VS 2030 Figure 52. Pediatric Influenza Treatment Industrial Chain Figure 53. Pediatric Influenza Treatment Manufacturing Cost Structure Figure 54. Channels of Distribution (Direct Sales, and Distribution) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation